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方法：将 8 周龄 SD 雄性大鼠随机分为三组：正常对照组（Ctrl 组）、糖尿病
组（DM 组）、当归四逆汤加减方治疗组（DSD 组）。DM 组和 DSD 组大鼠接受
链脲佐菌素（streptozotocin,STZ）腹腔注射，以诱导大鼠 1 型糖尿病模型。DSD




经；运用 QT-PCR(Quantitative Real Time PCR)和 weastern blot 检测大鼠坐骨神经
和施万细胞中 FASN、ACC-1、HMGCR、CPT-1、LXR-α、LXR-β、SREBP-1c
和 SREBP-2 等脂代谢相关蛋白的表达情况；运用 EdU 试验和 CCK8 试验检测施
万细胞增殖和存活能力。 
结果：动物实验中，DSD 不改变糖尿病大鼠的血糖和体重；与 Ctrl 组相比，
DM 组大鼠末梢神经显著减少，坐骨神经髓鞘结构出现明显异常，S100β蛋白表
达量显著下降（P<0.01），FASN、LXRs 和 SREBP-1c mRNA 和蛋白表达也显著
下降（P<0.05）；MBP 仅 mRNA 表达显著下降（P<0.05），其中 S100β、LXR-α、
SREBP-1c 和 FASN 的下调可被 DSD 治疗显著改善（P<0.05）；除 DM 组的 MBP 
和 ACC-1 mRNA 较 Ctrl 组显著下降（P<0.05），以及 CPT-1 mRNA 较 Ctrl 组显

















著降低（P<0.01），DSD 药物血清干预可显著增高其增殖和存活能力；与 Ctrl 组
相比，缺氧或高糖合并缺氧条件下施万细胞 LXR-α、SREBP-1c、FASN 和 HMGCR
蛋白表达显著下降（P<0.05）；DSD 药物血清干预可明显逆转施万细胞中 LXR-α、




α/SREBP-1c 信号通路，提高 FASN 的表达，从而促进脂肪酸合成，对改善 DPN
周围神经髓鞘的异常具有积极作用。 


















Objective：Diabetic peripheral neuropathy(DPN) is one of the most common 
diabetic complications, which can lead to pain, numbness, cold and other neurological 
symptoms, even lead to serious disability. Our previous studies have shown that 
Danggui Sini Decoction (DSD) can significantly improve the neurological symptoms 
in DPN patients, and sciatic nerve demyelination in diabetic rats. AS the myelin layers 
of neural axons are surrounded by Schwann cells, and major components of which are 
lipids, we thus hypothesis that DPN demyelination is closely associated with diabetes 
induced- disordered lipid metabolism in Schwann cells. The present study was 
designed to investigate the lipids metabolism in the sciatic nerve of diabetic rats and 
cultured Schwann cells, underhigh glucose or hypoxic conditions, thus to explore 
whether DSD could alliviate DPN through improving lipid metabolism. 
Methods：The 8-week old male SD rats were randomly divided into the folling 
groups:control group(Ctrl group),diabetic group(DM group) and Danggui Sini 
Decoction group(DSD group).Rats in DM and DSD group reveived intraperitoneal 
injection of Streptozotocin(STZ) to induce type 1 diabetes rat model. DSD group was 
treated with Danggui Sini Decoction, while Ctrl and DSD group were treated with 
normal saline by daily gastric gavage for 13 weeks. Random blood glucose and body 
weight of rats were measured every week; lesions of myelin were measured by 
Transmission Electron microscopy; expression of S100β in rat sciatic nerve tissue and 
PGP9.5(Protein gene product9.5, marker of nerve fiber) in peripheral nerve under 
epidermis of rat hind paw pad were detected by immune fluorescence detection 
technology; expression of S100β、MBP、 FASN、ACC-1、CPT-1、HMGCR、LXR-α、
LXR-β、SREBP-1c and SREBP-2 in sciatic nerve and Schwann cells was determined 
by QT-PCR(Quantitative real time PCR) and western blot; Schwann cells 















Results：In the in vivo experiment,DSD had no effect on the rat body weight and 
blood sugar; In comparison to normal group, the sciatic nerve myelin structure of rats 
in DM group was obviously abnormal,expression of S100β was significantly 
decreased,and the expression of lipid metabolism related genes including FASN、
LXR-α and SREBP-1c declined significantly in diabetic group(P<0.05),amoung 
which，the decrease of S100β、LXR-α、SREBP-1c and FASN in diabetic group could 
be reversed by DSD treatment efficiently; Apart from MBP 、ACC-1 and CPT-1 
mRNA expression were different between DM group and DSD group（P<0.05）, there 
are no difference of the expression of MBP、ACC-1、HMGCR、LXR-α、LXR-β and 
SREBP-2 among three group. In the in vitro experiments, EdU and CCK8 assay 
revealed that Schwann cell proliferation and viability were significantly decreased 
under hypoxic or high glucose combined with hypoxic condiction,DSD could 
significantly increased schwann cell proliferation and viability(P<0.01)；Expression of 
LXR-α、SREBP-1c and FASN in Schwann cells were significantly decreased when 
exposed to hypoxic or high glucose combined with hypoxic condiction(P<0.05), 
which could be reversed significantly when treated with medicated serum derived 
from low/high dose DSD treated rats,but there was no effect on HMGCR. 
Conclusion：1.Animal experiments have shown that DSD can significantly 
improve the loss of peripheral nerve and the abnormal structure of myelin in diabetic 
rats.2.Cell experiments have shown that DSD can significantly enhance the 
proliferation and viability of Schwann cell.3.Combined with animal and cell 
experiments,DSD can increase the expression of FASN by activating LXRα
/SREBP-1c signaling pathway,so as to promote the synthesis of fatty acid and then 
improve Diabetic Peripheral Neuropathy. 
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